Orthocell Limited (ASX:OCC)

Orthocell Statistics

Total Valuation

Orthocell has a market cap or net worth of AUD 269.28 million. The enterprise value is 241.24 million.

Market Cap	269.28M
Enterprise Value	241.24M

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Orthocell has 244.80 million shares outstanding. The number of shares has increased by 10.52% in one year.

Current Share Class	244.80M
Shares Outstanding	244.80M
Shares Change (YoY)	+10.52%
Shares Change (QoQ)	+6.71%
Owned by Insiders (%)	15.11%
Owned by Institutions (%)	2.97%
Float	207.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.66
PB Ratio	18.48
P/TBV Ratio	19.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.16
EV / Sales	31.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-26.97

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.04.

Current Ratio	4.97
Quick Ratio	4.76
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -89.70% and return on invested capital (ROIC) is -80.22%.

Return on Equity (ROE)	-89.70%
Return on Assets (ROA)	-26.42%
Return on Invested Capital (ROIC)	-80.22%
Return on Capital Employed (ROCE)	-45.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	2.31

Taxes

Income Tax	-3.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +144.44% in the last 52 weeks. The beta is 0.09, so Orthocell's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	+144.44%
50-Day Moving Average	1.23
200-Day Moving Average	1.32
Relative Strength Index (RSI)	35.78
Average Volume (20 Days)	402,211

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orthocell had revenue of AUD 7.55 million and -8.57 million in losses. Loss per share was -0.04.

Revenue	7.55M
Gross Profit	4.80M
Operating Income	-13.07M
Pretax Income	-11.75M
Net Income	-8.57M
EBITDA	-12.70M
EBIT	-13.07M
Loss Per Share	-0.04

Balance Sheet

The company has 28.62 million in cash and 576,895 in debt, giving a net cash position of 28.04 million or 0.11 per share.

Cash & Cash Equivalents	28.62M
Total Debt	576,895
Net Cash	28.04M
Net Cash Per Share	0.11
Equity (Book Value)	14.57M
Book Value Per Share	0.06
Working Capital	25.43M

Cash Flow

In the last 12 months, operating cash flow was -8.68 million and capital expenditures -260,420, giving a free cash flow of -8.94 million.

Operating Cash Flow	-8.68M
Capital Expenditures	-260,420
Free Cash Flow	-8.94M
FCF Per Share	-0.04

Margins

Gross margin is 63.63%, with operating and profit margins of -173.12% and -113.46%.

Gross Margin	63.63%
Operating Margin	-173.12%
Pretax Margin	-155.64%
Profit Margin	-113.46%
EBITDA Margin	-168.14%
EBIT Margin	-173.12%
FCF Margin	n/a

Dividends & Yields

Orthocell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.52%
Shareholder Yield	n/a
Earnings Yield	-3.18%
FCF Yield	-3.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Orthocell has an Altman Z-Score of 3.58 and a Piotroski F-Score of 2.

Altman Z-Score	3.58
Piotroski F-Score	2